Serious Risk
Serious risk in a clinical trial that indicates the potential for a serious adverse event.
Serious risk in a clinical trial that indicates the potential for a serious adverse event.
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.